Adenovirusmediated interleukin12 gene therapy for metastatic colon carcinoma 1216. Engineering adenoassociated viral vectors for glial. Comprehensive and authoritative, viral vectors for gene therapy. Schaffer department of chemical engineering and helen wills neuroscience institute, university of california, 201 gilman hall, berkeley, california, 94720. Genes transferred by viral vectors have dominated the clinical trials in gene therapy because they are more efficient and specific than physical and chemical methods.
Tissuespecific targeting of viral vectors is a key requirement for safe and efficient gene therapy. In fact, all three classes of replicationdefective adv. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy of the gene to restore the function of the protein. A proof of concept of viral gene therapy has been demonstrated by a large number of animal. Viral vectors for gene therapy stanford university. The huge potential for gene therapy to cure a wide range of diseases has led to high expectations and a great increase in research efforts in this area, particularly in the study of delivery via viral vectors, widely considered to be more efficient than dna transfection. The two major classes of methods are those that use recombinant viruses sometimes called biological nanoparticles or viral vectors and those that use naked dna or dna complexes non viral methods. This volume discusses protocols, ranging from vector production to delivery methods, used to execute gene therapy applications. N2 to achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on nontarget cells.
Gene delivery vectors based on retroviral or lentiviral particles are considered powerful tools for biomedicine and biotechnology applications. Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. This is because the non viral vectormediated dna transfer is not stably maintained in the nucleus and the transgenes are delivered at low levels to the target cells. Most adenoviral vectors used in gene therapy are derived from group c human serotype 2 and 5, which are the most common in nature. Engineering biomaterial systems to enhance viral vector. However, many viral vectors transduce a broad range of cell types. However, to date, no approach has focused on improving viral vectors for efficient gene delivery to the nervous system. Viral vectors for gene therapy 703 biochemistry moscow vol. Genetic manipulation of cells for scientific and therapeutic goals can be achieved by both. The concept of gene therapy seems straightforward, but this is clearly an oversimplification, and numerous problems and risks exist that prevent gene therapy using viral vectors.
However, nonspecific targeting to diseased cells and activation of the host immune response hinder its therapeutic efficacy. Methods and protocols provides not only researchers with the basic tools needed to design targeted gene delivery vectors, but also clinicians with an understanding of how to apply viral vectors to the treatment of genetic disorders. The natural tropism of some viruses matches their vector utility, as is the case for the herpes virus, which can be used for neuronal gene delivery. Properties of vectors for gene therapy for gene therapy to be successful, an appropriate amount of a therapeutic gene must be delivered into the target tissue without substantial toxicity. One of the ratelimiting steps for successful gene therapy is the efficiency of gene transfer. Viral vectors have frequently been applied in gene therapy with the final goal of treating var. Development of targeted viral vectors for cardiovascular gene. Surfaceengineered viral vectors for selective and cell. Apr 24, 2019 with the advent of more than 12 different gene therapy drugs for curing cancer, blindness, immune, and neuronal disorders, this emerging experimental medicine has yet again come in the limelight. Development of novel cell surface cd34targeted recombinant. The application of cancer gene therapy has heretofore been restricted to local, or locoregional, neoplastic disease contexts. Adenoviral vectors for gene therapy, second edition provides detailed, comprehensive coverage of the gene delivery vehicles that are based on the adenovirus that is emerging as an important tool in gene therapy. Gene therapy utilizes the delivery of dna into cells, which can be accomplished by several methods, summarized below. A brief history of using viral vectors for gene therapy 64 pioneering studies with ex vivo gene therapy.
Viral vectors for gene delivery in tissue engineering. Thus, many investigations have focused on how to engineer retroviral vectors into targeted gene delivery vehicles. Selective gene delivery exclusively into the cell type relevant for the desired application requires receptor targeted rt viral vectors, which can be generated by engineering of the aav capsid proteins or the glycoproteins incorporated into lv particles. In order to overcome this obstacle, many attempts have been made towards modifying the viral capsid protein to enhance aav targeting in specific tissues and cells, while also inhibiting transduction in nontarget tissues. Gene therapy is also used by inactivating mutated genes that are causing the disease using viruses. Exploring gene therapy troup county school district. Gene therapy has enormous potential to provide new treatments that strike directly at the heart. There has been a longlasting interest in using viral vectors, especially adenoviral vectors, for gene therapy in the past two decades. Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. Engineering targeted viral vectors for gene therapy nature. A key factor in the success of gene therapy is the development of gene delivery systems that are capable of efficient gene transfer in a broad variety of tissues, without causing any pathogenic effect. Schaffer, chair gene therapy the introduction of genetic material into cells and tissues of interest for a.
Viral gene delivery using retroviral vectors remains one of the most promising techniques for gene therapy 1, 2. Genetic engineering of targeted retroviral vectors vector. Genetic engineering has made enormous contributions to science, industry, agriculture, and medicine. For certain situations, one may prefer to deliver genes in a celltype specific manner, alleviating the offtarget effect 3, 4. Viruses can usually infect more than one type of cell. Hand out the exploring gene therapy webquest student pages s1 s4. Engineering targeted viral vectors for gene therapy semantic scholar. Those are the main properties that make viruses highly attractive gene delivery vehicles or vectors. Viral vectors for gene therapy berkeley university of california. Selfassembly of dna nanohydrogels with controllable size and stimuliresponsive property for targeted gene regulation therapy. T1 engineering targeted viral vectors for gene therapy.
High transfection efficiency and low toxicity achieved by increasing molecular weight. Significant improvements in vector engineering, delivery, and safety have placed viral. Genetic engineering of targeted retroviral vectors. This and some other genetic defects of the immune system see below were chosen as targets for gene therapy not only because. Library selection and directed evolution approaches to. Recent advances on the development of gene delivery systems, particularly on viral vectors engineering and improved gene regulatory systems, have led to. Request pdf engineering targeted viral vectors for gene therapy to achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding. Comparison of gene delivery to the kidney by adenovirus.
Recent developments in viral vector engineering that utilize highthroughput random diversification and selection platforms have advanced the rapid creation of novel aav vectors with new gene delivery properties. Sitespecific integration by adenoassociated virus 1128811294. Engineering targeted viral vectors for gene therapy mayo clinic. The development of viral vectors for gene therapy has had an interesting and somewhat. Each viral vector system is characterized by an inherent set of properties that affect its suitability for specific gene therapy applications. Viral vector design and construction creative biolabs. This is due, in part, to the stringent filtering functions intrinsic to the kidney. Viruses that have been used for gene therapy are, adenovirus. Oncogenic potential of the adenovirus e4orf6 protein 1129511. Improving plasmid and viral vectors in cell and gene therapy. Abstract gene transfer into b cells by lentivectors can provide an alternative approach to managing b lymphocyte malignancies and autoreactive b cellmediated autoimmune diseases.
This method requires the incorporation of two distinct molecules on the viral vector surface. Dec 16, 2019 while gene therapy has made great strides over the past 30 years to treat diseases in other tissues, relatively little progress has been made in targeting kidney diseases. Human gene therapy has been attempted on somatic body cells for diseases such as cystic fibrosis and cancer. May 15, 2008 we have reported a method to target lentiviral vectors to specific cell types. Request pdf engineering targeted viral vectors for gene therapy to achieve therapeutic success, transfer vehicles for gene therapy must be capable of. Methods and protocols is a valuable resource for researchers, clinicians, and students looking to utilize viral vectors in gene therapy experiments. This chapter outlines the design strategies applied for enhancing aav targeting through direct and indirect targeting methods.
Engineering adenoassociated virus for protease targeted gene. Comprehensive and highly practical, viral vectors for gene therapy. Adenoassociated virus aav vectors have recently become a promising therapeutic gene delivery vehicle due to their nonpathogenicity and ability to establish longterm gene. In general, viral vectors have an advantage over non viral vectors in terms of gene transfer efficiency. Generally, synthetic nanoparticles are lipidbased, polymeric, or based on.
As a vaccine platform, viral vectors can be used for expression and presentation of pathogenic antigens to induce an immune response by mimicking a natural infection. Frontiers gene therapy leaves a vicious cycle oncology. Pharmacodynamics of antihiv gene therapy using viral vectors. Improvement of specificity can be achieved by direct vector application into a defined location within the organ. Efficacy and safety of adenoassociated viral vectors based on serotype 8 and 9 vs. In a range of human trials, viral vectors have emerged as safe and effective delivery vehicles for clinical gene therapy, particularly for monogenic recessive disorders, but there has also been early work on some idiopathic diseases. Targeted strategies to engineer viral vectors for human gene.
Nas colloquium genetic engineering of viruses and viral vectors. Review targeted approaches to induce immune tolerance for. Engineering fusogenic molecules to achieve targeted. Pharmacodynamics of antihiv gene therapy using viral. Viral vectors for gene therapy methods and protocols. Gene therapy applications of viral vectors sage journals. These exciting new therapeutic agents have great potential for the treatment of disease, making gene therapy a fastgrowing field for research.
Key features it provides an excellent overview on a series of topics on gene therapy for the serious investigator. Gene therapy, introduction of a normal gene into an individuals genome in order to repair a mutation that causes a genetic disease. These successes have been enabled by research and development efforts focusing on vectors that combine low genotoxicity and immunogenicity with highly efficient. When viewed in the context of the quantitative properties of hiv infection in vivo, the apparently inevitable development of resistance following drug monotherapy illustrates a potential advantage for gene therapy of hiv disease. Engineering adenoassociated virus vectors for gene therapy. We used fluorescence histograms from flow cytometry experiments to infer the number of transgene copies expressed in single cells at a given dose. Ghivizzani gene therapy is now being applied to the treatment of a wide variety of acquired and inherited diseases. Viral vectors are designed to be safe by making them incapable of replication. Up to 30 kbp of the 36 kbp wild type adenoviral genome can be replaced by foreign dna.
Such vectors require modification at the genomic level in the form of rearrangements to allow introduction of desired genes and regulatory elements genotypic modification as well as engineering of the physical virus particle. Analysis of aav serotypes 19 mediated gene expression and tropism in mice after systemic injection. Applications of viral vectors and nonviral gene delivery systems have found an. Engineering targeted viral vectors for gene therapy. In recent years, advancement in the development of gene transfer techniques as well as identification of target genes for numerous disorders of both acquired and inherited nature has driven an explosion of published work in the field of gene therapy. A brief account of viral vectors and their promise for gene therapy. This attribute has led to extensive attempts to engineer recombinant viral vectors for the delivery of thera. Engineering targeted viral vectors for gene therapy ncbi nih. Genetic engineering of viruses and of virus vectors. In gene therapy, viral vectors can be used for delivery of functional genes to replace defective genes to cure genetic disorders. Emphasis is placed on the molecular bases of drug action, both applied and experimental.
Besides viral vectors, non viral or synthetic vectors are being developed for gene therapy. Engineering of novel adenoassociated virus vectors for gene therapy applications by jorge luis santiago ortiz doctor of philosophy in chemical engineering university of california, berkeley professor david v. These successes have been enabled by research and development efforts focusing on vectors that combine low genotoxicity and immunogenicity. Genetic modification involves the directed insertion, deletion, artificial synthesis or change of nucleotide bases in viral genomes. The main groups of viral vectors applied for gene therapy are summarized below and in table1, followed by examples of both preclinical table2 and clinical. Adenoassociated virus aav has earned significant attention as a safe and efficient gene therapy tool.
Figure 2 from engineering targeted viral vectors for gene. Gene therapy uses genetically modified viruses to deliver genes that can cure diseases in human cells. Finally, the approval of viral vectorbased drugs is discussed. Viral vectors for use in gene therapy, cell therapy, and in. Adenoassociated virus aav vectors are promising human gene delivery vehicles due to their ability to establish longterm gene expression in a wide variety of target tissues. Aav has been used in over 100 clinical trials to treat a variety of human diseases. This is owing to the lack of gene transfer vectors, which embody the requisite target cell selectivity in vivo required for metastatic disease applications. Molecular engineering and evolution of adenoassociated viral vectors for enhanced gene transfer 1 september 2007 pharmaceutical research, vol. Chapters cover topics such as design and construction of transcription activationlike effectors and multimodal production of adenoassociated virus. Crisprcas9based cellular engineering for targeted gene overexpression. Here, we describe a mechanistic mathematical model of gene therapy that focuses on the delivery and expression of reporter genes transported by viral vectors to target cells. Viral and nonviral vectors can be 25 to 200 nm in diameter and have masses in megadaltons. Gene therapy for parkinsons disease pd since the early days of experimental gene therapy for other disorders, pd was considered an ideal brain disease for this approach,1 because of the relatively selective. Engineering targeted viral vectors for gene therapy mayo.
Mar 15, 2019 besides viral vectors, non viral or synthetic vectors are being developed for gene therapy. Gene therapies are gaining momentum as promising early successes in clinical studies accumulate and examples of regulatory approval for licensing increase. Targeting tumor neoangiogenesis via targeted adenoviral. Generation of targeted adenoassociated virus aav vectors. Currently, viral vectors based on many different viruses have been developed, and their performance and pathogenicity has been evaluated in animal models. Fortunately, vectorengineering efforts are demonstrating promise in the development of nextgeneration gene therapy vectors that can overcome. Volume 40, genetherapy, features important new research on gene transfers and therapy in the herpes simplex virus, antitumor immunity, steroid receptors, cystic fibroses, and more. Targeted strategies to engineer viral vectors for human. The main groups of viral vectors applied for gene therapy are. Engineering targeted viral vectors for gene therapy request pdf. Postexit surface engineering of retrovirallentiviral vectors. Viruses that have been used for gene therapy are, adenovirus, lentivirus, retrovirus and the herpes simplex virus.
Examples of viral vectors applied for gene therapy. Investigators are advancing with cautious optimism that effective, durable, and safe therapies will provide benefit to patientsnot only those with singlegene disorders but those with complex acquired diseases as well. By virtue of their action through watsoncrick base pairing, only nucleic acids antisense molecules and ribozymes can presently be. A role for adenoassociated viral vectors in gene therapy scielo. Vectors used in gene therapy can trigger the bodys natural immune response. Library selection and directed evolution approaches to engineering targeted viral vectors jaehyung jang, kwangil lim, david v.
Engineering of novel adenoassociated virus vectors for. A brief history of using viral vectors for gene therapy pioneering studies with ex vivo gene therapy for immunode. Development of hiv vectors for antihiv gene therapy. To achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on nontarget cells. A genetically modified virus is a virus that has been altered or generated using biotechnology methods, and remains capable of infection. Cystic fibrosis has been targeted by aavbased expression of the cystic. Random peptide libraries displayed on adenoassociated virus to select for targeted gene therapy vectors. Request pdf targeted strategies to engineer viral vectors for human gene therapy adenoassociated virus aav vectors have recently become a promising therapeutic gene delivery vehicle due to. Article information, pdf download for viral vector systems for gene therapy.
1055 796 1038 220 674 1374 1240 1376 1061 1556 1514 703 193 690 401 1001 98 696 186 966 6 563 538 1274 205 284 1232 1347 1259 161 1232 500 1384 1156 413 964 609